The antineutrophil cytoplasmic antibodies (ANCA typical or not) in current medical practice

被引：4
|
作者：
Renaudineau, Y. [3 ]
Beauvillard, D. [3 ]
Segalen, I. [2 ,3 ]
Leroyer, C. [1 ]
Le Meur, Y. [2 ]
Youinou, P. [1 ]
机构：
[1] CHU Brest, Hop Cavale Blanche, Serv Pneumol, F-29609 Brest, France
[2] CHU Brest, Hop Cavale Blanche, Serv Nephrol, F-29609 Brest, France
[3] CHU Brest, Hop Morvan, Immunol Lab, F-29609 Brest, France
来源：
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE | 2011年 / 26卷 / 01期
关键词：
Antineutrophil cytoplasmic antibodies (ANCA); Vasculitis; Proteinase; 3; Myeloperoxidase (MPO); INTERNATIONAL CONSENSUS STATEMENT; WEGENERS-GRANULOMATOSIS; NECROTIZING GLOMERULONEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; SYSTEMIC VASCULITIS; DISEASE-ACTIVITY; AUTOANTIBODIES; PROTEINASE-3; NEUTROPHILS; MYELOPEROXIDASE;
D O I：
10.1016/j.immbio.2010.12.002
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Antineutrophil cytoplasmic antibodies (ANCA) are important serological markers mostly for the small vessel systemic vasculitides. Numerous reports have established an interest for the combination of the indirect immunofluorescence (IFI) and the ELISA anti-PR3 and anti-MPO in such indication. However, conflicting results may exist between IFI and ELISA that require additional assays and such special measures are important to help and avoid clinical misinterpretation. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：27 / 34
页数：8
相关论文
共 50 条
  • [1] Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: do we need to revise the international consensus statement on testing and reporting on ANCA?
    Tervaert, Jan Willem Cohen
    Damoiseaux, Jan
    APMIS, 2009, 117 : 55 - 59
  • [2] Antineutrophil cytoplasmic antibodies in pneumology
    Ghrairi, N.
    Bouakkez, H.
    Nandi, I.
    Dahmouni, A.
    Yalaoui, S.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2011, 26 (03): : 137 - 142
  • [3] What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige, J
    Pollock, W
    Trevisin, M
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (02): : 263 - 276
  • [4] ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN MYELODYSPLASIA AND OTHER HEMATOLOGICAL DISORDERS
    SAVIGE, JA
    CHANG, L
    SMITH, CL
    DUGGAN, JC
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1994, 24 (03): : 282 - 287
  • [5] Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype
    Mohammad, Aladdin J.
    Mortensen, Kristian H.
    Babar, Judith
    Smith, Rona
    Jones, Rachel B.
    Nakagomi, Daiki
    Sivasothy, Pasupathy
    Jayne, David R. W.
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (10) : 1458 - 1467
  • [6] Antineutrophil cytoplasmic antibodies and associated diseases
    Sghiri, R.
    Meddeb, H.
    Bouguila, J.
    Jarray, M.
    Bahri, F.
    Nouira, R.
    Zellama, D.
    Achour, A.
    Essoussi, A. S.
    Harbi, A.
    Ghedira, I.
    PATHOLOGIE BIOLOGIE, 2009, 57 (05): : 398 - 402
  • [7] New aspects of antineutrophil cytoplasmic antibodies (ANCA) in vasculitides
    Csernok, E
    Reichel, P
    Gross, WL
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2002, 61 (04): : 367 - 377
  • [8] Antineutrophil cytoplasmic antibodies (ANCA) testing: detection methods and clinical application
    Sinico, R. A.
    Radice, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S112 - S117
  • [9] ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) - THEIR DETECTION AND SIGNIFICANCE - REPORT FROM WORKSHOPS
    SAVIGE, JA
    DAVIES, DJ
    GATENBY, PA
    PATHOLOGY, 1994, 26 (02) : 186 - 193
  • [10] Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA)
    Pollock, Wendy
    Jovanovich, Sue
    Savige, Judy
    JOURNAL OF IMMUNOLOGICAL METHODS, 2009, 347 (1-2) : 19 - 23
12345